Mature Progression-Free Survival in Stage IV Non-Small Cell Lung Cancer Patients Treated With Pemetrexed Maintenance Therapy

被引:0
|
作者
Bhatt, P. [1 ]
Bonomi, P. [1 ]
Basu, S. [2 ]
Batus, M. [1 ]
机构
[1] Rush Univ, Med Ctr, Sect Med Oncol, Chicago, IL 60612 USA
[2] Rush Univ, Med Ctr, Chicago, IL 60612 USA
关键词
PROGRESSION FREE SURVIVAL; non small cell lung cancer; Premetrexed;
D O I
10.1016/j.jtho.2018.08.1565
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3.01-05
引用
收藏
页码:S868 / S869
页数:2
相关论文
共 50 条
  • [1] Prognostic Model for Progression-Free Survival in Patients With Stage III Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation
    Peulen, H. M.
    Uyterlinde, W.
    Belderbos, J.
    Vincent, A.
    Korse, C.
    van Diessen, J.
    Sonke, J. J.
    van den Heuvel, M. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S657 - S657
  • [2] Impact of PTVon progression-free survival in inoperable stage III non-small cell lung cancer patients treated with chemoradioimmunotherapy
    Taugner, J.
    Karin, M.
    Kaesmann, L.
    Eze, C.
    Floersch, B.
    Guggenberger, J.
    Tufman, A.
    Belka, C.
    Manapov, F.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S741 - S742
  • [4] Predictive Factors for Poor Progression-free Survival in Patients with Non-small Cell Lung Cancer Treated with Nivolumab
    Taniguchi, Yoshihiko
    Tamiya, Akihiro
    Isa, Syun-Ichi
    Nakahama, Kenji
    Okishio, Kyoichi
    Shiroyama, Takayuki
    Suzuki, Hidekazu
    Inoue, Takako
    Tamiya, Motohiro
    Hirashima, Tomonori
    Imamura, Fumio
    Atagi, Shinji
    ANTICANCER RESEARCH, 2017, 37 (10) : 5857 - 5862
  • [5] Effect of etoposide plus thalidomide as maintenance therapy on progression-free survival of elderly patients with advanced non-small cell lung cancer
    Yanan Ge
    Zhendong Zheng
    Zhaozhe Liu
    Jianing Qiu
    Xiaodong Xie
    OncologyandTranslationalMedicine, 2017, 3 (03) : 103 - 107
  • [6] A radiomics prognostic scoring system for predicting progression-free survival in patients with stage IV non-small cell lung cancer treated with platinum-based chemotherapy
    He, Lan
    Li, Zhenhui
    Chen, Xin
    Huang, Yanqi
    Yan, Lixu
    Liang, Changhong
    Liu, Zaiyi
    CHINESE JOURNAL OF CANCER RESEARCH, 2021, 33 (05) : 592 - +
  • [7] Mature, real world progression-free survival (PFS) and overall survival (OS) milestones in stage IV, non-squamous, non-small cell lung cancer patients (nsqNSCLC) treated with first line pemetrexed(Pem)/platinum(Plat) followed by pem plus /- bevacizumab(Bev) maintenance.
    Bhatt, Parva Kiran
    Fughhi, Ibtihaj
    Basu, Sanjib
    Fidler, Mary J.
    Borgia, Jeffrey Allen
    Bonomi, Philip D.
    Batus, Marta
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy
    Zachary D Horne
    David A Clump
    John A Vargo
    Samir Shah
    Sushil Beriwal
    Steven A Burton
    Annette E Quinn
    Matthew J Schuchert
    Rodney J Landreneau
    Neil A Christie
    James D Luketich
    Dwight E Heron
    Radiation Oncology, 9
  • [9] Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy
    Horne, Zachary D.
    Clump, David A.
    Vargo, John A.
    Shah, Samir
    Beriwal, Sushil
    Burton, Steven A.
    Quinn, Annette E.
    Schuchert, Matthew J.
    Landreneau, Rodney J.
    Christie, Neil A.
    Luketich, James D.
    Heron, Dwight E.
    RADIATION ONCOLOGY, 2014, 9
  • [10] Anaplastic Lymphoma Kinase Gene Rearrangements in Non-small Cell Lung Cancer are Associated with Prolonged Progression-Free Survival on Pemetrexed
    Camidge, D. Ross
    Kono, Scott A.
    Lu, Xian
    Okuyama, Sonia
    Baron, Anna E.
    Oton, Ana B.
    Davies, Angela M.
    Varella-Garcia, Marileila
    Franklin, Wilbur
    Doebele, Robert C.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (04) : 774 - 780